Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

L.A. McKeown

May 19, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

News Daily News

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

L.A. McKeown

December 04, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News TCT 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

Yael L. Maxwell

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

Presentation JIM 2016

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

Presenter: Antonio L. Bartorelli

February 10, 2016

News Features

精益求精：创新支架技术值得继续探索

Todd Neale

November 08, 2015

Advertisement

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

TCTMD’s Top 10 Most Popular Stories for September 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

精益求精：创新支架技术值得继续探索

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content